UK Space Biomed Consortium

英国空间生物医学战略造福英国英国空间生物医学联盟由来自英国各地的多个学术组织和工业公司的27个机构组成。该联盟正在确定，并将提出、批准和随后实施一项战略，重点是加强学术和工业组织之间的沟通、协调和合作，并在适当情况下加强政府组织之间的沟通、协调和合作。该战略旨在正式建立和发展空间生物医学，将其作为英国国内的一个领域。它将集中英国空间生物医学联盟成员(和任何未来成员)的资源，以实现以下目标。艾姆西。惠及地面医疗保健。二、促进英国创新和经济增长。三、让英国做好有效参与未来载人航天活动的准备。四、有利于/服务于英国SBC成员的利益。促进并受益于国际合作。展望英国空间生物医学联盟的成员将开始一项行动，这将导致英国境内的空间生物医学领域得到正式承认。由该联盟协调并在全国范围内开展的空间生物医学活动将减少人口老龄化的负面影响，改善地面医疗保健服务，并为即将到来的新空间时代(基于商业载人航天)做好准备。2.英国空间生物医学联合会打算建立一个研究所，其成员来自学术界和工业界，他们将根据以下主题制定4个研发和商业产品方案：1.老龄化、生活方式和营养2.远程医疗/电子保健/生物技术3.与太空旅行有关的发病率。4.人的因素和绩效。

A UK Space Biomedicine Strategy for the Benefit of the UKThe UK Space Biomedicine Consortium consists of 27 establishments from a number of academic organisations and industrial companies from across the UK. The Consortium is in the process of identifying, and will propose, ratify and subsequently pursue a strategy centred upon augmented communication, coordination and collaboration between academic and industrial, and where appropriate, Governmental, organisations. The strategy aims to formally establish and develop space biomedicine as a field within the UK. It will focus the resources of the UK Space Biomedicine Consortium members (and any future members) to enable the following aims to be achieved. AIMSi. Benefit terrestrial healthcare. ii. Enhance UK innovation and economic growth. iii. Prepare the UK to effectively participate in future human spaceflight activities. iv. Benefit / serve the interests of UKSBC members.v. Contribute to, and benefit from, international collaboration.Vision The members of the UK Space Biomedicine Consortium will embark upon a course of action that shall result in the official recognition of the domain of space biomedicine within the UK. The space biomedicine activities coordinated by the Consortium and undertaken across the nation will diminish the negative impact of an ageing population, improve terrestrial healthcare provision and prepare the country for the new space era that approaches (one based upon commercial human spaceflight). The UK Space Biomedicine Consortium intends to establish itself as an Institute with members drawn from academia and industry, who shall develop 4 R&D and commercial product programmes according to the following themes;1. Ageing, Lifestyle & Nutrition2. Telemedicine / e-Health / Biotechnology 3. Morbidity in relation to space travel. 4. Human Factors and Performance.